{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:19:41Z","timestamp":1793755181295,"version":"4.6.1"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T00:00:00Z","timestamp":1686355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T00:00:00Z","timestamp":1686355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010564","name":"Academic Medical Organization of Southwestern Ontario","doi-asserted-by":"publisher","award":["INNO20-029"],"award-info":[{"award-number":["INNO20-029"]}],"id":[{"id":"10.13039\/100010564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Long-COVID occurs after SARS-CoV-2 infection and results in diverse, prolonged symptoms. The present study aimed to unveil potential mechanisms, and to inform prognosis and treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Plasma proteome from Long-COVID outpatients was analyzed in comparison to matched acutely ill COVID-19 (mild and severe) inpatients and healthy control subjects. The expression of 3072 protein biomarkers was determined with proximity extension assays and then deconvoluted with multiple bioinformatics tools into both cell types and signaling mechanisms, as well as organ specificity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared to age- and sex-matched acutely ill COVID-19 inpatients and healthy control subjects, Long-COVID outpatients showed natural killer cell redistribution with a dominant resting phenotype, as opposed to active, and neutrophils that formed extracellular traps. This potential resetting of cell phenotypes was reflected in prospective vascular events mediated by both angiopoietin-1 (ANGPT1) and vascular-endothelial growth factor-A (VEGFA). Several markers (ANGPT1, VEGFA, CCR7, CD56, citrullinated histone 3, elastase) were validated by serological methods in additional patient cohorts. Signaling of transforming growth factor-\u03b21 with probable connections to elevated\u00a0EP\/p300 suggested vascular inflammation and tumor necrosis factor-\u03b1 driven pathways. In addition, a vascular proliferative state associated with hypoxia inducible factor 1 pathway suggested progression from acute COVID-19 to Long-COVID. The vasculo-proliferative process predicted in Long-COVID might contribute to changes in the organ-specific proteome reflective of neurologic and cardiometabolic dysfunction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Taken together, our findings point to a vasculo-proliferative process in Long-COVID that is likely initiated either prior hypoxia (localized or systemic) and\/or stimulatory factors\u00a0(i.e., cytokines, chemokines, growth factors, angiotensin, etc). Analyses of the plasma proteome, used as a surrogate for cellular signaling, unveiled potential organ-specific prognostic biomarkers and therapeutic targets.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-023-04149-9","type":"journal-article","created":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T09:02:03Z","timestamp":1686387723000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Plasma proteome of Long-COVID patients indicates HIF-mediated vasculo-proliferative disease with impact on brain and heart function"],"prefix":"10.1186","volume":"21","author":[{"given":"Cristiana","family":"Iosef","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Knauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Logan R.","family":"Van Nynatten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gediminas","family":"Cepinskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorin","family":"Draghici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor K. M.","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas D.","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,10]]},"reference":[{"issue":"1","key":"4149_CR1","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1080\/07853890.2022.2076901","volume":"54","author":"D Castanares-Zapatero","year":"2022","unstructured":"Castanares-Zapatero D, Chalon P, Kohn L, Dauvrin M, Detollenaere J, et al. Pathophysiology and mechanism of Long-COVID: a comprehensive review. Ann Med. 2022;54(1):1473\u201387.","journal-title":"Ann Med"},{"issue":"399","key":"4149_CR2","first-page":"10322","volume":"22","author":"K Brown","year":"2022","unstructured":"Brown K, Yahyouche A, Haroon S, Camaradou J, Turner J. Long-COVID and self-management. Lancet. 2022;22(399):10322\u201355.","journal-title":"Lancet"},{"key":"4149_CR3","unstructured":"World Health Organization WHO R&D Blueprint. Novel Coronavirus. COVID-19 Therapeutic Trial Synopsis.https:\/\/cdn.who.int\/media\/docs\/default-source\/blue-print\/covid-19-therapeutic-trial-synopsis.pdf?sfvrsn=44b83344_1&download=true."},{"issue":"1","key":"4149_CR4","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s10020-022-00548-8","volume":"28","author":"MA Patel","year":"2022","unstructured":"Patel MA, Knauer MJ, Nicholson M, Daley M, Van Nynatten LR, Martin C, et al. Elevated vascular transformation blood biomarkers in long-COVID indicate angiogenesis as a key pathophysiological mechanism. Molec Med. 2022;28(1):122. https:\/\/doi.org\/10.1186\/s10020-022-00548-8.","journal-title":"Molec Med"},{"issue":"1","key":"4149_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s10020-023-00610-z","volume":"29","author":"MA Patel","year":"2023","unstructured":"Patel MA, Knauer MJ, Nicholson M, Daley M, Van Nynatten LR, Cepinskas G, Fraser DD. Organ and cell-specific biomarkers of Long-COVID identified with targeted proteomics and machine learning. Mol Med. 2023;29(1):26.","journal-title":"Mol Med"},{"issue":"7862","key":"4149_CR6","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41586-021-03553-9","volume":"594","author":"Z Al-Aly","year":"2021","unstructured":"Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594(7862):259\u201364.","journal-title":"Nature"},{"issue":"4","key":"4149_CR7","doi-asserted-by":"publisher","first-page":"e2315","DOI":"10.1002\/rmv.2315","volume":"32","author":"SJ Yong","year":"2022","unstructured":"Yong SJ, Shiliang L. Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies. Rev Med Virol. 2022;32(4):e2315.","journal-title":"Rev Med Virol"},{"issue":"10343","key":"4149_CR8","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/S0140-6736(22)00941-2","volume":"399","author":"M Antonelli","year":"2022","unstructured":"Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of Long-COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399(10343):2263\u20134.","journal-title":"Lancet"},{"issue":"6579","key":"4149_CR9","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1126\/science.ada0536","volume":"375","author":"J Couzin-Frankel","year":"2022","unstructured":"Couzin-Frankel J, Vogel G. Vaccines may cause rare, long-COVID-like symptoms. Science. 2022;375(6579):364\u20136.","journal-title":"Science"},{"issue":"5","key":"4149_CR10","doi-asserted-by":"publisher","first-page":"103071","DOI":"10.1016\/j.autrev.2022.103071","volume":"21","author":"A Dotan","year":"2022","unstructured":"Dotan A, David P, Arnheim D, Shoenfeld Y. The autonomic aspects of the post-COVID19 syndrome. Autoimmun Rev. 2022;21(5):103071.","journal-title":"Autoimmun Rev"},{"issue":"7922","key":"4149_CR11","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/d41586-022-02140-w","volume":"608","author":"H Ledford","year":"2022","unstructured":"Ledford H. Long-COVID treatments: why the world is still waiting. Nature. 2022;608(7922):258\u201360.","journal-title":"Nature"},{"issue":"5","key":"4149_CR12","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.cell.2022.01.014","volume":"185","author":"Y Su","year":"2022","unstructured":"Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, Li S, Hong S, Zhang R, Xie J, Kornilov SA, Scherler K, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185(5):881\u201395.","journal-title":"Cell"},{"issue":"3","key":"4149_CR13","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.immuni.2022.01.017","volume":"55","author":"B Vijayakumar","year":"2022","unstructured":"Vijayakumar B, Boustani K, Ogger PP, Papadaki A, Tonkin J, Orton CM, Ghai P, Suveizdyte K, et al. Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease. Immunity. 2022;55(3):542\u201356.","journal-title":"Immunity"},{"issue":"6","key":"4149_CR14","doi-asserted-by":"publisher","first-page":"e0144","DOI":"10.1097\/CCE.0000000000000144","volume":"2","author":"DD Fraser","year":"2020","unstructured":"Fraser DD, Cepinskas G, Slessarev M, Martin C, Daley M, Miller MR, et al. Inflammation Profiling of Critically Ill Coronavirus Disease 2019 Patients. Crit Care Explor. 2020;2(6):e0144. https:\/\/doi.org\/10.1097\/CCE.0000000000000144.","journal-title":"Crit Care Explor"},{"key":"4149_CR15","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","volume":"20","author":"E Dong","year":"2020","unstructured":"Dong E, Du H, Gardner H. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20:533\u20134.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"4149_CR16","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","volume":"27","author":"A Nalbandian","year":"2021","unstructured":"Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, Cook JR, Nordvig AS, Shalev D, et al. Post-acute COVID-19 syndrome. Nat Med Nat Med. 2021;27(4):601\u201315.","journal-title":"Nat Med Nat Med"},{"key":"4149_CR17","doi-asserted-by":"publisher","first-page":"e241485","DOI":"10.1136\/bcr-2020-241485","volume":"14","author":"P Taribagil","year":"2021","unstructured":"Taribagil P, Creer D, Tahir D. \u2018Long-COVID\u2019 syndrome. BMJ Case Rep. 2021;14:e241485. https:\/\/doi.org\/10.1136\/bcr-2020-241485.","journal-title":"BMJ Case Rep"},{"issue":"7","key":"4149_CR18","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/s41591-022-01840-0","volume":"28","author":"Z Al-Aly","year":"2022","unstructured":"Al-Aly Z, Bowe B, Xie Y. Long-COVID after breakthrough SARS-CoV-2 infection. Nat Med. 2022;28(7):1461\u20137.","journal-title":"Nat Med"},{"key":"4149_CR19","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/s41591-020-0944-y","volume":"26","author":"AJ Wilk","year":"2020","unstructured":"Wilk AJ, Rustagi A, Zhao NQ, Roque J, Mart\u00ednez-Col\u00f3n GJ, McKechnie JL, et al. A single-cell atlas of the peripheral immune response in patients with severe COVID-19. Nat Med. 2020;26:1070\u20136.","journal-title":"Nat Med"},{"issue":"1","key":"4149_CR20","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12933-022-01623-4","volume":"21","author":"A Kruger","year":"2022","unstructured":"Kruger A, Vlok M, Turner S, Venter C, Laubscher GJ, Kell DB, Pretorius E. Proteomics of fibrin amyloid microclots in Long-COVID\/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system. Cardiovasc Diabeto. 2022;21(1):190. https:\/\/doi.org\/10.1186\/s12933-022-01623-4.","journal-title":"Cardiovasc Diabeto"},{"issue":"8","key":"4149_CR21","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.cels.2021.05.005","volume":"12","author":"V Demichev","year":"2021","unstructured":"Demichev V, Tober-Lau P, Lemke O, Nazarenko T, Thibeault C, Whitwell H, R\u00f6hl A, Freiwald A, Szyrwiel L, Ludwig D, Correia-Melo C, et al. A time-resolved proteomic and prognostic map of COVID-19. Cell Syst. 2021;12(8):780\u201394.","journal-title":"Cell Syst"},{"issue":"5","key":"4149_CR22","doi-asserted-by":"publisher","first-page":"100287","DOI":"10.1016\/j.xcrm.2021.100287","volume":"2","author":"MR Filbin","year":"2021","unstructured":"Filbin MR, et al. Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions. Cell Rep Med. 2021;2(5):100287.","journal-title":"Cell Rep Med"},{"issue":"5","key":"4149_CR23","doi-asserted-by":"publisher","first-page":"100287","DOI":"10.1016\/j.xcrm.2021.100287","volume":"2","author":"MR Filbin","year":"2021","unstructured":"Filbin MR, Mehta A, Schneider AM, Kays KR, Guess JR, Gentili M, Fenyves BG, Charland NC, Gonye ALK, et al. Novel outcome biomarkers identified with targeted proteomic analyses of plasma from critically Ill coronavirus disease 2019 patients. Cell Rep Med. 2021;2(5):100287.","journal-title":"Cell Rep Med"},{"issue":"8","key":"4149_CR24","doi-asserted-by":"publisher","first-page":"e14532","DOI":"10.15252\/emmm.202114532","volume":"13","author":"D Memon","year":"2021","unstructured":"Memon D, Barrio-Hernandez I, Beltrao P. Individual COVID-19 disease trajectories revealed by plasma proteomics. EMBO Mol Med. 2021;13(8):e14532.","journal-title":"EMBO Mol Med"},{"key":"4149_CR25","doi-asserted-by":"publisher","first-page":"807149","DOI":"10.3389\/fcell.2022.807149","volume":"10","author":"P Vedula","year":"2022","unstructured":"Vedula P, Tang HY, Speicher DW, Kashina A. Protein posttranslational signatures identified in COVID-19 patient plasma. Front Cell Dev Biol. 2022;10:807149.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"4149_CR26","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/s41467-022-28639-4","volume":"13","author":"MAY Al-Nesf","year":"2022","unstructured":"Al-Nesf MAY, Abdesselem HB, Bensmail I, Ibrahim S, Saeed WAH, Mohammed SSI, Razok A, Alhussain H, et al. Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications. Nat Commun. 2022;13(1):946. https:\/\/doi.org\/10.1038\/s41467-022-28639-4.","journal-title":"Nat Commun"},{"key":"4149_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100680","author":"D Feyaerts","year":"2021","unstructured":"Feyaerts D, H\u00e9dou J, Gillard J, Chen H, Tsai ES, Peterson LS, et al. Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19. bioRxiv. 2021. https:\/\/doi.org\/10.1016\/j.xcrm.2022.100680.","journal-title":"bioRxiv"},{"issue":"7","key":"4149_CR28","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/s42255-021-00425-4","volume":"3","author":"SM Lam","year":"2021","unstructured":"Lam SM, Zhang C, Wang Z, Ni Z, Zhang S, Yang S, Huang X, Mo L, et al. A multi-omics investigation of the composition and function of extracellular vesicles along the temporal trajectory of COVID-19. Nat Metab. 2021;3(7):909\u201322.","journal-title":"Nat Metab"},{"issue":"5","key":"4149_CR29","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s41591-021-01329-2","volume":"27","author":"AJ Rostron","year":"2021","unstructured":"Rostron AJ, Simpson AJ, Hambleton S, Laurenti E, Lyons PA, Meyer KB, Nikoli\u0107 MZ, Duncan CJA, Smith KGC, et al. Single-cell multi-omics analysis of the immune response in COVID-19. Nat Med. 2021;27(5):904\u201316.","journal-title":"Nat Med"},{"issue":"1","key":"4149_CR30","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/jcmm.17622","volume":"27","author":"C Iosef","year":"2023","unstructured":"Iosef C, Martin CM, Slessarev M, Gillio-Meina C, Cepinskas G, Han VKM, Fraser DD. COVID-19 plasma proteome reveals novel temporal and cell-specific signatures for disease severity and high-precision disease management. J Cell Mol Med. 2023;27(1):141\u201357. https:\/\/doi.org\/10.1111\/jcmm.17622.","journal-title":"J Cell Mol Med."},{"issue":"6508","key":"4149_CR31","doi-asserted-by":"publisher","first-page":"8511","DOI":"10.1126\/science.abc8511","volume":"369","author":"D Mathew","year":"2020","unstructured":"Mathew D, Giles JR, Baxter AE, Oldridge DA, Greenplate AR, Wu JE, Alanio C, Kuri-Cervantes L, Pampena MB, D\u2019Andrea K, Manne S, et al. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science. 2020;369(6508):8511.","journal-title":"Science"},{"key":"4149_CR32","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1038\/s41591-020-1038-6","volume":"26","author":"AG Laing","year":"2020","unstructured":"Laing AG, Lorenc A, Del Molino Barrio I, Das A, Fish M, Monin L, Mu\u00f1oz-Ruiz M, McKenzie DR, Hayday TS, Francos-Quijorna I, Kamdar S, et al. A dynamic COVID-19 immune signature includes associations with poor prognosis. Nat Med. 2020;26:1623\u201335.","journal-title":"Nat Med"},{"issue":"3","key":"4149_CR33","doi-asserted-by":"publisher","first-page":"e0369","DOI":"10.1097\/CCE.0000000000000369","volume":"3","author":"DD Fraser","year":"2021","unstructured":"Fraser DD, Cepinskas G, Slessarev M, Martin CM, Daley M, Patel MA, et al. Detection and profiling of human coronavirus immunoglobulins in critically Ill coronavirus disease 2019 patients. Crit Care Explor. 2021;3(3):e0369. https:\/\/doi.org\/10.1097\/CCE.0000000000000369.","journal-title":"Crit Care Explor"},{"key":"4149_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2022.101602","author":"LA Lupisella","year":"2022","unstructured":"Lupisella LA, Parvin SS, Wurtz TR, Garcia RA. Formyl peptide receptor 2 and heart disease. Semin Immunol. 2022. https:\/\/doi.org\/10.1016\/j.smim.2022.101602.","journal-title":"Semin Immunol"},{"issue":"15","key":"4149_CR35","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1093\/nar\/gkr424","volume":"39","author":"M Lundberg","year":"2011","unstructured":"Lundberg M, Eriksson A, Tran B, Assarsson E, Fredrickson S. Homogenous antibody-based proximity ligation assay provides sensitive and specific detection or low abundant proteins in human blood. Nucl Acid Res. 2011;39(15):e102. https:\/\/doi.org\/10.1093\/nar\/gkr424.","journal-title":"Nucl Acid Res"},{"issue":"6508","key":"4149_CR36","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1126\/science.abc6261","volume":"369","author":"PS Arunachalam","year":"2020","unstructured":"Arunachalam PS, Wimmers F, Mok CKP, Perera RAPM, Scott M, Hagan T, Sigal N, Feng Y, Bristow L, et al. Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans. Science. 2020;369(6508):1210\u201320. https:\/\/doi.org\/10.1126\/science.abc6261.","journal-title":"Science"},{"key":"4149_CR37","doi-asserted-by":"publisher","first-page":"652584","DOI":"10.3389\/fcvm.2021.652584","volume":"8","author":"PL M\u00f8ller","year":"2021","unstructured":"M\u00f8ller PL, Rohde PD, Winther S, Breining P, Nissen L, Nykjaer A, B\u00f8ttcher M, Nyegaard M, Kjolby M. Sortilin as a biomarker for cardiovascular disease revisited. Front Cardiovasc Med. 2021;8:652584. https:\/\/doi.org\/10.3389\/fcvm.2021.652584.","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"4149_CR38","doi-asserted-by":"publisher","first-page":"e2200031","DOI":"10.1002\/prca.202200031","volume":"16","author":"J Zhao","year":"2022","unstructured":"Zhao J, Schank M, Wang L, Dang X, Cao D, Khanal S, Nguyen LNT, Zhang Y, Wu XY, Adkins JL, Pelton BJ, et al. Plasma biomarkers for systemic inflammation in COVID-19 survivors. Proteomics Clin Appl. 2022;16(5):e2200031. https:\/\/doi.org\/10.1002\/prca.202200031.","journal-title":"Proteomics Clin Appl"},{"issue":"5","key":"4149_CR39","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.immuni.2020.10.008","volume":"53","author":"T Shu","year":"2020","unstructured":"Shu T, Ning W, Wu D, Xu J, Han Q, Huang M, Zou X, Yang Q, Yuan Y, Bie Y, Pan S, Mu J, Han Y, et al. Plasma proteomics identify biomarkers and pathogenesis of COVID-19. Immunity. 2020;53(5):1108\u201322. https:\/\/doi.org\/10.1016\/j.immuni.2020.10.008.","journal-title":"Immunity"},{"issue":"9","key":"4149_CR40","doi-asserted-by":"publisher","first-page":"e0189","DOI":"10.1097\/CCE.0000000000000189","volume":"2","author":"DD Fraser","year":"2020","unstructured":"Fraser DD, Cepinskas G, Patterson EK, Slessarev M, Martin C, Daley M, Patel MA, Miller MR, O\u2019Gorman DB, Gill SE, Pare G, Prassas I, Diamandis E. Novel Outcome Biomarkers Identified With Targeted Proteomic Analyses of Plasma From Critically Ill Coronavirus Disease 2019 Patients. Crit Care Explor. 2020;2(9):e0189. https:\/\/doi.org\/10.1097\/CCE.0000000000000189.","journal-title":"Crit Care Explor."},{"issue":"12","key":"4149_CR41","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1038\/s41591-019-0665-2","volume":"25","author":"SA Williams","year":"2019","unstructured":"Williams SA, Kivimaki M, Langenberg C, Hingorani AD, Casas JP, Bouchard C, Jonasson C, Sarzynski MA, et al. Plasma protein patterns as comprehensive indicators of health. Nat Med. 2019;25(12):1851\u20137.","journal-title":"Nat Med"},{"issue":"D1","key":"4149_CR42","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P, Jensen LJ, Mering CV. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607\u201313. https:\/\/doi.org\/10.1093\/nar\/gky1131.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"4149_CR43","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1101\/gr.6202607","volume":"17","author":"S Draghici","year":"2007","unstructured":"Draghici S, Khatri P, Tarca AL, Amin K, Done A, Voichita C, Georgescu C, Romero R. A systems biology approach for pathway level analysis. Genome Res. 2007;17(10):1537\u201345.","journal-title":"Genome Res"},{"issue":"7708","key":"4149_CR44","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41586-018-0175-2","volume":"558","author":"BB Sun","year":"2018","unstructured":"Sun BB, Maranville JC, Peters JE, Stacey D, Staley JR, Blackshaw J, Burgess S, Jiang T, Paige E, et al. Genomic atlas of the human plasma proteome. Nature. 2018;558(7708):73\u20139. https:\/\/doi.org\/10.1038\/s41586-018-0175-2.","journal-title":"Nature"},{"issue":"10","key":"4149_CR45","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3389\/fgene.2019.00159","volume":"19","author":"A Shafi","year":"2019","unstructured":"Shafi A, Nguyen T, Peyvandipour A, Nguyen H, Draghici S. A multi-cohort and multi-omics meta-analysis framework to identify network-based gene signatures. Front Genet. 2019;19(10):159. https:\/\/doi.org\/10.3389\/fgene.2019.00159.","journal-title":"Front Genet"},{"issue":"1","key":"4149_CR46","doi-asserted-by":"publisher","first-page":"4188","DOI":"10.1038\/s41598-020-60981-9","volume":"10","author":"T Nguyen","year":"2020","unstructured":"Nguyen T, Shafi A, Nguyen TM, Schissler AG, Draghici S. NBIA: a network-based integrative analysis framework\u2014applied to pathway analysis. Sci Rep. 2020;10(1):4188. https:\/\/doi.org\/10.1038\/s41598-020-60981-9.","journal-title":"Sci Rep"},{"key":"4149_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/S2589-7500(22)00048-6","author":"ER Pfaff","year":"2022","unstructured":"Pfaff ER, Girvin AT, Bennett TD, Bhatia A, Brooks IM, Deer RR, Dekermanjian JP, Jolley SE, Kahn MG, Kostka K, et al. N3C Consortium Identifying who has long COVID in the USA a machine learning approach using N3C data. Lancet Digit Health. 2022. https:\/\/doi.org\/10.1016\/S2589-7500(22)00048-6.","journal-title":"Lancet Digit Health"},{"issue":"5","key":"4149_CR48","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, Hoang CD, Diehn M, Alizadeh AA. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137. https:\/\/doi.org\/10.1038\/nmeth.3337.","journal-title":"Nat Methods"},{"issue":"6508","key":"4149_CR49","doi-asserted-by":"publisher","first-page":"8511","DOI":"10.1126\/science.abc8511","volume":"369","author":"D Mathew","year":"2020","unstructured":"Mathew D, Giles JR, Baxter AE, Oldridge DA, Greenplate AR, Wu JE, Alanio C, Kuri-Cervantes L, Pampena MB, D\u2019Andrea K, Manne S, et al. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science. 2020;369(6508):8511. https:\/\/doi.org\/10.1126\/science.abc8511.","journal-title":"Science"},{"key":"4149_CR50","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1038\/s41591-020-1038-6","volume":"26","author":"AG Laing","year":"2020","unstructured":"Laing AG, Lorenc A, Molino Del, Del Barrio I, Das A, Fish M, Monin L, Mu\u00f1oz-Ruiz M, McKenzie DR, Hayday TS, et al. A dynamic COVID-19 immune signature includes associations with poor prognosis. Nat Med. 2020;26:1623\u201335.","journal-title":"Nat Med"},{"issue":"5","key":"4149_CR51","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/MOH.0000000000000361","volume":"24","author":"SM Parikh","year":"2017","unstructured":"Parikh SM. The angiopoietins and Tie in vascular inflammation. Curr Oppinion Hematol. 2017;24(5):432\u20138.","journal-title":"Curr Oppinion Hematol"},{"key":"4149_CR52","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.cell.2020.08.002","volume":"182","author":"A Silvin","year":"2020","unstructured":"Silvin A, Chapuis N, Dunsmore G, Goubet AG, Dubuisson A, Derosa L, Almire C, H\u00e9non C, Kosmider O, Droin N, Rameau P, Catelain C, Alfaro A, et al. Elevated calprotection and abnormal myeloid cell subsets discriminate severe from mild COVID19. Cell. 2020;182:1401\u201318.","journal-title":"Cell"},{"key":"4149_CR53","doi-asserted-by":"publisher","DOI":"10.1101\/2022.03.23.22272828","author":"CM Rice","year":"2022","unstructured":"Rice CM, Lewis P, Ponce-Garcia FM, Willem Gibbs D, Cela F, et al. Neutrophils in COVID19 are characterized by hyperactive immature state and maintained CXR2 expression. medRix. 2022. https:\/\/doi.org\/10.1101\/2022.03.23.22272828.","journal-title":"medRix"},{"issue":"1","key":"4149_CR54","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41591-021-01576-3","volume":"28","author":"S Sinha","year":"2022","unstructured":"Sinha S, Rosin NL, Arora R, Labit E, Jaffer A, Cao L, Farias R, Nguyen AP, de Almeida LGN, et al. Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19. Nat Med. 2022;28(1):201\u201311.","journal-title":"Nat Med"},{"issue":"5","key":"4149_CR55","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1182\/bloodadvances.2020003568","volume":"5","author":"ML Meizlish","year":"2021","unstructured":"Meizlish ML, Pine AB, Bishai JD, Goshua G, Nadelmann ER, Simonov M, Chang CH, Zhang H, Shallow M, Bahel P, Owusu K, et al. A neutrophil activation signature predicts critical illness and mortality in COVID-19. Blood Adv. 2021;5(5):1164\u201377.","journal-title":"Blood Adv"},{"key":"4149_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.12:810286.10.3389\/fimmu.2021.810286","author":"ZW Liu","year":"2021","unstructured":"Liu ZW, Zhang YM, Zhang LY, Zhou T, Li YY, Zhou GC, Miao ZM, et al. Duality of interactions between TGF-\u03b2 and TNF-\u03b1 during tumor formation. Front Immunol. 2021. https:\/\/doi.org\/10.3389\/fimmu.12:810286.10.3389\/fimmu.2021.810286.","journal-title":"Front Immunol"},{"issue":"12","key":"4149_CR57","doi-asserted-by":"publisher","first-page":"6702","DOI":"10.1093\/nar\/gkac488","volume":"50","author":"Aj Portuguez","year":"2022","unstructured":"Portuguez Aj, Grbesa I, Tal M, Deitch R, Raz D, Kliker L, Weismann R, Schwartz M, Loza O, Cohen L, Marchenkov-Flam L, et al. Ep300 sequestration to functionally distinct glucocorticoid receptor binding loci underlie rapid gene activation and repression. Nucl Ac Res. 2022;50(12):6702\u201314.","journal-title":"Nucl Ac Res"},{"issue":"26","key":"4149_CR58","doi-asserted-by":"publisher","first-page":"12942","DOI":"10.1073\/pnas.1821565116","volume":"116","author":"K Dendoncker","year":"2019","unstructured":"Dendoncker K, Timmermans S, Vandewalle J, Eggermont M, Lempi\u00e4inen J, Paakinaho V, Van Hamme E, Dewaele S, Vandevyver S, et al. TNF-\u03b1 inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile. Proc Natl Acad Sci USA. 2019;116(26):12942\u201351.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4149_CR59","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/onc.2012.191","volume":"32","author":"Morikawa","year":"2013","unstructured":"Morikawa, et al. Genome-wide mechanisms of Smad binding. Oncogene. 2013;32:1609\u201315.","journal-title":"Oncogene"},{"issue":"1","key":"4149_CR60","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s00415-021-10655-x","volume":"269","author":"J Hugon","year":"2022","unstructured":"Hugon J, Msika EF, Queneau M, Farid K, Paquet C. Long-COVID: cognitive complaints (brain fog) and dysfunction of the cingulate cortex. J Neurol. 2022;269(1):44\u20136. https:\/\/doi.org\/10.1007\/s00415-021-10655-x.","journal-title":"J Neurol"},{"key":"4149_CR61","unstructured":"ENTREZ: https:\/\/www.ncbi.nlm.nih.gov\/gene\/4088; https:\/\/www.ncbi.nlm.nih.gov\/gene?Db=gene&Cmd=ShowDetailView&TermToSearch=2033"},{"key":"4149_CR62","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2021.0500","author":"M Boldrini","year":"2021","unstructured":"Boldrini M, Canoll PD, Klein RS. How COVID-19 affects the brain. JAMA Psychiat. 2021. https:\/\/doi.org\/10.1001\/jamapsychiatry.2021.0500.","journal-title":"JAMA Psychiat"},{"key":"4149_CR63","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S1474-4422(20)30221-0","volume":"19","author":"MA Ellul","year":"2020","unstructured":"Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, Kneen R, Defres S, Sejvar J, Solomon T. Neurological associations of COVID-19. Lancet Neurol. 2020;19:767\u201383. https:\/\/doi.org\/10.1016\/S1474-4422(20)30221-0.","journal-title":"Lancet Neurol"},{"issue":"1","key":"4149_CR64","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1038\/s41467-022-30932-1","volume":"13","author":"M Charnley","year":"2022","unstructured":"Charnley M, Islam S, Bindra GK, Engwirda J, Ratcliffe J, Zhou J, Mezzenga R, Hulett MD, Han K, Berryman JT, Reynolds NP. Neurotoxic amyloidogenic peptides in the proteome of SARS-COV2: potential implications for neurological symptoms in COVID-19. Nat Commun. 2022;13(1):3387. https:\/\/doi.org\/10.1038\/s41467-022-30932-1.","journal-title":"Nat Commun"},{"issue":"2","key":"4149_CR65","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s10549-017-4633-6","volume":"167","author":"M Asaduzzaman","year":"2018","unstructured":"Asaduzzaman M, Constantinou S, Min H, Gallon J, Lin ML, Singh P, Raguz S, Ali S, Shousha S, Coombes RC, Lam EW, Hu Y, Yag\u00fce E. Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer. Breast Cancer Res Treat. 2018;167(2):605\u20136.","journal-title":"Breast Cancer Res Treat"},{"key":"4149_CR66","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41591-022-01689-3","volume":"28","author":"Y Xie","year":"2022","unstructured":"Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28:583\u201390. https:\/\/doi.org\/10.1038\/s41591-022-01689-3.","journal-title":"Nat Med"},{"issue":"1","key":"4149_CR67","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.gendis.2021.08.004","volume":"9","author":"Z Zeng","year":"2022","unstructured":"Zeng Z, Lan T, Wei Y, Wei X. CCL5\/CCR5 axis in human diseases and related treatments. Genes Dis. 2022;9(1):12\u201327.","journal-title":"Genes Dis"},{"issue":"1","key":"4149_CR68","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1186\/s12885-020-07573-y","volume":"20","author":"A Ring","year":"2020","unstructured":"Ring A, Kaur P, Lang JE. EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer. BMC Cancer. 2020;20(1):1076.","journal-title":"BMC Cancer"},{"issue":"7","key":"4149_CR69","first-page":"414","volume":"7","author":"S Pesce","year":"2016","unstructured":"Pesce S, Moretta L, Moretta A, Marcenaro E. Human NK cell subsets redistribution in pathological conditions: a role for CCR7 receptor. Front Immunol. 2016;7(7):414.","journal-title":"Front Immunol"},{"issue":"10","key":"4149_CR70","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1182\/blood-2008-08-172742","volume":"113","author":"TK Ito","year":"2009","unstructured":"Ito TK, Ishi G, Saito S, Iano K, Suziki T, Ochiai A, Ito TK, Ishi G, Saito S, Iano K, Suziki T, Ochiai A. Degradation of soluble VEGF receptor-1 by MMP-7 allows VEGF access to endothelial cells. Blood. 2009;113(10):2363\u20139.","journal-title":"Blood"},{"issue":"12","key":"4149_CR71","doi-asserted-by":"publisher","first-page":"700782","DOI":"10.3389\/fimmu.2021.700782","volume":"28","author":"BK Patterson","year":"2021","unstructured":"Patterson BK, Guevara-Coto J, Yogendra R, Francisco EB, Long E, Pise A, Rodrigues H, Parikh P, Mora J, Mora-Rodr\u00edguez RA. Immune-based prediction of COVID-19 severity and chronicity decoded using machine learning. Front Immunol. 2021;28(12):700782.","journal-title":"Front Immunol"},{"issue":"12","key":"4149_CR72","doi-asserted-by":"publisher","first-page":"746021","DOI":"10.3389\/fimmu.2021.746021","volume":"10","author":"BK Patterson","year":"2022","unstructured":"Patterson BK, Francisco EB, Yogendra R, Long E, Pise A, Rodrigues H, Hall E, et al. Persistence of SARS CoV-2 S1 protein in CD16+ monocytes in post-acute sequelae of COVID-19 (PASC) up to 15 months post-infection. Front Immunol. 2022;10(12):746021.","journal-title":"Front Immunol"},{"key":"4149_CR73","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12931-020-01462-5","volume":"21","author":"S Dhont","year":"2020","unstructured":"Dhont S, Derom E, Van Braeckel E, Depuydt P, Lambrecht BN. The pathophysiology of \u2018happy\u2019 hypoxemia in COVID-19. Respir Res. 2020;21:198.","journal-title":"Respir Res"},{"key":"4149_CR74","doi-asserted-by":"publisher","first-page":"745634","DOI":"10.3389\/fphys.2021.745634","volume":"12","author":"E Akoumianaki","year":"2021","unstructured":"Akoumianaki E, Vaporidi K, Bolaki M, Georgopoulos D. Happy or silent hypoxia in COVID-19\u2013a misnomer born in the pandemic era. Front Physiol. 2021;12:745634.","journal-title":"Front Physiol"},{"issue":"2","key":"4149_CR75","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1189\/jlb.71.2.173","volume":"71","author":"M Robertson","year":"2002","unstructured":"Robertson M. Role of chemokines in the biology of natural killer cells. J Leukoc Biol. 2002;71(2):173\u201383.","journal-title":"J Leukoc Biol"},{"issue":"1","key":"4149_CR76","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.gendis.2021.08.004","volume":"9","author":"Z Zeng","year":"2022","unstructured":"Zeng Z, Lan T, Wei Y, Wei X. CCL5\/CCR5 axis in human diseases and related treatments. Genes Dis. 2022;9(1):12\u201327.","journal-title":"Genes Dis"},{"issue":"1","key":"4149_CR77","doi-asserted-by":"publisher","first-page":"105717","DOI":"10.1016\/j.isci.2022.105717","volume":"26","author":"JJ Kovarik","year":"2023","unstructured":"Kovarik JJ, Bileck A, Hagn G, Meier-Menches SM, Frey T, Kaempf A, Hollenstein M, Shoumariyeh T, Skos L, Reiter B, Gerner MC, Spannbauer A, Hasimbegovic E, Schmidl D, Garh\u00f6fer G, Gy\u00f6ngy\u00f6si M, Schmetterer KG, Gerner C. A multi-omics based anti-inflammatory immune signature characterizes long COVID-19 syndrome. iScience. 2023;26(1):105717.","journal-title":"iScience"},{"key":"4149_CR78","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41586-021-04142-6","volume":"600","author":"M Witkowski","year":"2021","unstructured":"Witkowski M, Tizian C, Ferreira-Gomes M, et al. Untimely TGF\u03b2 responses in COVID-19 limit antiviral functions of NK cells. Nature. 2021;600:295\u2013301.","journal-title":"Nature"},{"issue":"5","key":"4149_CR79","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.3390\/s23052473","volume":"23","author":"EAMC Adang","year":"2023","unstructured":"Adang EAMC, Strous MTA, van den Bergh JP, Gach D, van Kampen VEM, van Zeeland REP, Barten DG, van Osch FHM. Association of heart rate variability with pulmonary function impairment and symptomatology post-COVID-19 hospitalization. Sensors. 2023;23(5):2473.","journal-title":"Sensors"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04149-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-04149-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04149-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T06:06:43Z","timestamp":1687846003000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-04149-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,10]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4149"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-04149-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2448315\/v1","asserted-by":"object"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,10]]},"assertion":[{"value":"5 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Supplementary file Figure S5A contained the word ENDOTELIAL in the title of the cartoon and it should be ENDOTHELIAL.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by Western University, Human Research Ethics Board (Long-COVID REB ID# 120084; COVID-19 REB ID# 1670; Healthy Control Subjects REB ID# 6963).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consented for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There are no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"377"}}